Leadership Team
Micah Rimer – President and CEO
Micah is a UC Davis computer science graduate, and built scalable vaccine tech platforms through two pandemics and spearheaded digital transformations at Bayer, Novartis, and GSK. Leading global teams across the US and Europe, he empowers R&D to deliver results faster by eliminating operational bottlenecks. He’s driven high-stakes programs—from M&A and divestments to major reorganizations—uniting diverse, multicultural teams around bold change agendas. Passionate about cutting non-value work, Micah now brings his proven track record of streamlined tech to deliver innovative solutions.
Nathaniel Katz – Chief Scientific Officer
Nat is a neurologist and pain management specialist with over 25 years of experience in clinical trials, including running a clinical research center at Brigham and Women’s Hospital in Boston. Dr. Katz has an advanced degree in statistics from Columbia, was Chairman of the Advisory Committee to the pain division of the FDA, a longstanding participant in IMMPACT, an FDA-industry-academia public-private partnership focused on improving clinical research methods, and the founder of a company, Analgesic Solutions, which successfully developed, validated, and commercialized online training tools and central statistical monitoring ecosystems to improve the reliability of clinical trials, leading to acquisition by WCG in 2019. Dr. Katz has over 200 publications in the fields of pain, development of analgesics, and clinical research methodology.
Heike Reinstaedtler – Sr. QA Advisor
Heike is an independent senior quality consultant supporting small biotech and start-ups in the area of clinical development quality. She has more than 30 years’ experience in the biotech industry focusing on quality in clinical R&D and drug development. Heike has built and developed quality teams and successfully led global teams through transformation and reorganization in different major companies including Novartis and GSK. She brings wide-ranging knowledge and deep understanding of Good Clinical Practice, Quality Management Systems, their operations and related technical solutions and developed methodology for audits of clinical trial sites, vendors and systems, including Trials Master Files. During her career, Heike has managed various inspections in the clinical and pharmacovigilance area working with inspectors from different health authorities including EMA, FDA and PMDA.
John Patti – Quality Systems advisor
John brings over 25 years of experience across the pharmaceutical and biotechnology industries, leading transformative quality and compliance initiatives at companies including GSK, Novartis, Ipsen, and Bayer. With deep expertise in computer system validation, 21 CFR Part 11, and data integrity, he has driven enterprise-wide system implementations and digital transformations that improved compliance, accelerated cycle times, and enabled global harmonization of critical GxP processes. John has led global remediation programs, advised companies under FDA enforcement actions, and overseen quality integration during complex M&A transitions. He combines operational excellence with pragmatic, risk-based thinking to deliver sustainable improvements in quality systems and digital compliance.